Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Personalized Cancer Medicine Revenue 1.4 Market Analysis by Type 1.4.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Monoclonal Antibodies 1.4.3 Personalized Cancer Vaccines 1.4.4 Other 1.5 Market by Application 1.5.1 Global Personalized Cancer Medicine Market Share by Application: 2020 VS 2026 1.5.2 Breast Cancer 1.5.3 Lung Cancer 1.5.4 Chronic Myeloid Leukaemia 1.5.5 Bowel Cancer 1.5.6 Other Cancer 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Personalized Cancer Medicine Market Perspective (2015-2026) 2.2 Personalized Cancer Medicine Growth Trends by Regions 2.2.1 Personalized Cancer Medicine Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Personalized Cancer Medicine Historic Market Share by Regions (2015-2020) 2.2.3 Personalized Cancer Medicine Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Personalized Cancer Medicine Market Growth Strategy 2.3.6 Primary Interviews with Key Personalized Cancer Medicine Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Personalized Cancer Medicine Players by Market Size 3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2015-2020) 3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2015-2020) 3.1.3 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Personalized Cancer Medicine Market Concentration Ratio 3.2.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2019 3.3 Personalized Cancer Medicine Key Players Head office and Area Served 3.4 Key Players Personalized Cancer Medicine Product Solution and Service 3.5 Date of Enter into Personalized Cancer Medicine Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2015-2020) 4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2021-2026) 5 Personalized Cancer Medicine Breakdown Data by Application (2015-2026) 5.1 Global Personalized Cancer Medicine Market Size by Application (2015-2020) 5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Personalized Cancer Medicine Market Size (2015-2020) 6.2 Personalized Cancer Medicine Key Players in North America (2019-2020) 6.3 North America Personalized Cancer Medicine Market Size by Type (2015-2020) 6.4 North America Personalized Cancer Medicine Market Size by Application (2015-2020) 7 Europe 7.1 Europe Personalized Cancer Medicine Market Size (2015-2020) 7.2 Personalized Cancer Medicine Key Players in Europe (2019-2020) 7.3 Europe Personalized Cancer Medicine Market Size by Type (2015-2020) 7.4 Europe Personalized Cancer Medicine Market Size by Application (2015-2020) 8 China 8.1 China Personalized Cancer Medicine Market Size (2015-2020) 8.2 Personalized Cancer Medicine Key Players in China (2019-2020) 8.3 China Personalized Cancer Medicine Market Size by Type (2015-2020) 8.4 China Personalized Cancer Medicine Market Size by Application (2015-2020) 9 Japan 9.1 Japan Personalized Cancer Medicine Market Size (2015-2020) 9.2 Personalized Cancer Medicine Key Players in Japan (2019-2020) 9.3 Japan Personalized Cancer Medicine Market Size by Type (2015-2020) 9.4 Japan Personalized Cancer Medicine Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Personalized Cancer Medicine Market Size (2015-2020) 10.2 Personalized Cancer Medicine Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Personalized Cancer Medicine Market Size by Type (2015-2020) 10.4 Southeast Asia Personalized Cancer Medicine Market Size by Application (2015-2020) 11 India 11.1 India Personalized Cancer Medicine Market Size (2015-2020) 11.2 Personalized Cancer Medicine Key Players in India (2019-2020) 11.3 India Personalized Cancer Medicine Market Size by Type (2015-2020) 11.4 India Personalized Cancer Medicine Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Personalized Cancer Medicine Market Size (2015-2020) 12.2 Personalized Cancer Medicine Key Players in Central & South America (2019-2020) 12.3 Central & South America Personalized Cancer Medicine Market Size by Type (2015-2020) 12.4 Central & South America Personalized Cancer Medicine Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Abbott 13.1.1 Abbott Company Details 13.1.2 Abbott Business Overview and Its Total Revenue 13.1.3 Abbott Personalized Cancer Medicine Introduction 13.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2015-2020)) 13.1.5 Abbott Recent Development 13.2 Merck 13.2.1 Merck Company Details 13.2.2 Merck Business Overview and Its Total Revenue 13.2.3 Merck Personalized Cancer Medicine Introduction 13.2.4 Merck Revenue in Personalized Cancer Medicine Business (2015-2020) 13.2.5 Merck Recent Development 13.3 Novartis 13.3.1 Novartis Company Details 13.3.2 Novartis Business Overview and Its Total Revenue 13.3.3 Novartis Personalized Cancer Medicine Introduction 13.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2015-2020) 13.3.5 Novartis Recent Development 13.4 Amgen 13.4.1 Amgen Company Details 13.4.2 Amgen Business Overview and Its Total Revenue 13.4.3 Amgen Personalized Cancer Medicine Introduction 13.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2015-2020) 13.4.5 Amgen Recent Development 13.5 Celgene 13.5.1 Celgene Company Details 13.5.2 Celgene Business Overview and Its Total Revenue 13.5.3 Celgene Personalized Cancer Medicine Introduction 13.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2015-2020) 13.5.5 Celgene Recent Development 13.6 Bayer 13.6.1 Bayer Company Details 13.6.2 Bayer Business Overview and Its Total Revenue 13.6.3 Bayer Personalized Cancer Medicine Introduction 13.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2015-2020) 13.6.5 Bayer Recent Development 13.7 Roche 13.7.1 Roche Company Details 13.7.2 Roche Business Overview and Its Total Revenue 13.7.3 Roche Personalized Cancer Medicine Introduction 13.7.4 Roche Revenue in Personalized Cancer Medicine Business (2015-2020) 13.7.5 Roche Recent Development 13.8 Astellas 13.8.1 Astellas Company Details 13.8.2 Astellas Business Overview and Its Total Revenue 13.8.3 Astellas Personalized Cancer Medicine Introduction 13.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2015-2020) 13.8.5 Astellas Recent Development 13.9 Astrazeneca 13.9.1 Astrazeneca Company Details 13.9.2 Astrazeneca Business Overview and Its Total Revenue 13.9.3 Astrazeneca Personalized Cancer Medicine Introduction 13.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2015-2020) 13.9.5 Astrazeneca Recent Development 13.10 Johnson & Johnson 13.10.1 Johnson & Johnson Company Details 13.10.2 Johnson & Johnson Business Overview and Its Total Revenue 13.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction 13.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2015-2020) 13.10.5 Johnson & Johnson Recent Development 13.11 Agilent 10.11.1 Agilent Company Details 10.11.2 Agilent Business Overview and Its Total Revenue 10.11.3 Agilent Personalized Cancer Medicine Introduction 10.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2015-2020) 10.11.5 Agilent Recent Development 13.12 Takeda 10.12.1 Takeda Company Details 10.12.2 Takeda Business Overview and Its Total Revenue 10.12.3 Takeda Personalized Cancer Medicine Introduction 10.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2015-2020) 10.12.5 Takeda Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Personalized Cancer Medicine Key Market Segments Table 2. Key Players Covered: Ranking by Personalized Cancer Medicine Revenue Table 3. Ranking of Global Top Personalized Cancer Medicine Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Personalized Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Monoclonal Antibodies Table 6. Key Players of Personalized Cancer Vaccines Table 7. Key Players of Other Table 8. Global Personalized Cancer Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Personalized Cancer Medicine Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Personalized Cancer Medicine Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Personalized Cancer Medicine Market Share by Regions (2015-2020) Table 12. Global Personalized Cancer Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Personalized Cancer Medicine Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Personalized Cancer Medicine Market Growth Strategy Table 18. Main Points Interviewed from Key Personalized Cancer Medicine Players Table 19. Global Personalized Cancer Medicine Revenue by Players (2015-2020) (Million US$) Table 20. Global Personalized Cancer Medicine Market Share by Players (2015-2020) Table 21. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Medicine as of 2019) Table 22. Global Personalized Cancer Medicine by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Personalized Cancer Medicine Product Solution and Service Table 25. Date of Enter into Personalized Cancer Medicine Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$) Table 28. Global Personalized Cancer Medicine Market Size Share by Type (2015-2020) Table 29. Global Personalized Cancer Medicine Revenue Market Share by Type (2021-2026) Table 30. Global Personalized Cancer Medicine Market Size Share by Application (2015-2020) Table 31. Global Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$) Table 32. Global Personalized Cancer Medicine Market Size Share by Application (2021-2026) Table 33. North America Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$) Table 34. North America Key Players Personalized Cancer Medicine Market Share (2019-2020) Table 35. North America Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$) Table 36. North America Personalized Cancer Medicine Market Share by Type (2015-2020) Table 37. North America Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$) Table 38. North America Personalized Cancer Medicine Market Share by Application (2015-2020) Table 39. Europe Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Personalized Cancer Medicine Market Share (2019-2020) Table 41. Europe Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$) Table 42. Europe Personalized Cancer Medicine Market Share by Type (2015-2020) Table 43. Europe Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$) Table 44. Europe Personalized Cancer Medicine Market Share by Application (2015-2020) Table 45. China Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$) Table 46. China Key Players Personalized Cancer Medicine Market Share (2019-2020) Table 47. China Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$) Table 48. China Personalized Cancer Medicine Market Share by Type (2015-2020) Table 49. China Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$) Table 50. China Personalized Cancer Medicine Market Share by Application (2015-2020) Table 51. Japan Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Personalized Cancer Medicine Market Share (2019-2020) Table 53. Japan Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$) Table 54. Japan Personalized Cancer Medicine Market Share by Type (2015-2020) Table 55. Japan Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$) Table 56. Japan Personalized Cancer Medicine Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Personalized Cancer Medicine Market Share (2019-2020) Table 59. Southeast Asia Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Personalized Cancer Medicine Market Share by Type (2015-2020) Table 61. Southeast Asia Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Personalized Cancer Medicine Market Share by Application (2015-2020) Table 63. India Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$) Table 64. India Key Players Personalized Cancer Medicine Market Share (2019-2020) Table 65. India Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$) Table 66. India Personalized Cancer Medicine Market Share by Type (2015-2020) Table 67. India Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$) Table 68. India Personalized Cancer Medicine Market Share by Application (2015-2020) Table 69. Central & South America Key Players Personalized Cancer Medicine Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Personalized Cancer Medicine Market Share (2019-2020) Table 71. Central & South America Personalized Cancer Medicine Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Personalized Cancer Medicine Market Share by Type (2015-2020) Table 73. Central & South America Personalized Cancer Medicine Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Personalized Cancer Medicine Market Share by Application (2015-2020) Table 75. Abbott Company Details Table 76. Abbott Business Overview Table 77. Abbott Product Table 78. Abbott Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 79. Abbott Recent Development Table 80. Merck Company Details Table 81. Merck Business Overview Table 82. Merck Product Table 83. Merck Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 84. Merck Recent Development Table 85. Novartis Company Details Table 86. Novartis Business Overview Table 87. Novartis Product Table 88. Novartis Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 89. Novartis Recent Development Table 90. Amgen Company Details Table 91. Amgen Business Overview Table 92. Amgen Product Table 93. Amgen Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 94. Amgen Recent Development Table 95. Celgene Company Details Table 96. Celgene Business Overview Table 97. Celgene Product Table 98. Celgene Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 99. Celgene Recent Development Table 100. Bayer Company Details Table 101. Bayer Business Overview Table 102. Bayer Product Table 103. Bayer Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 104. Bayer Recent Development Table 105. Roche Company Details Table 106. Roche Business Overview Table 107. Roche Product Table 108. Roche Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 109. Roche Recent Development Table 110. Astellas Business Overview Table 111. Astellas Product Table 112. Astellas Company Details Table 113. Astellas Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 114. Astellas Recent Development Table 115. Astrazeneca Company Details Table 116. Astrazeneca Business Overview Table 117. Astrazeneca Product Table 118. Astrazeneca Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 119. Astrazeneca Recent Development Table 120. Johnson & Johnson Company Details Table 121. Johnson & Johnson Business Overview Table 122. Johnson & Johnson Product Table 123. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 124. Johnson & Johnson Recent Development Table 125. Agilent Company Details Table 126. Agilent Business Overview Table 127. Agilent Product Table 128. Agilent Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 129. Agilent Recent Development Table 130. Takeda Company Details Table 131. Takeda Business Overview Table 132. Takeda Product Table 133. Takeda Revenue in Personalized Cancer Medicine Business (2015-2020) (Million US$) Table 134. Takeda Recent Development Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global Personalized Cancer Medicine Market Share by Type: 2020 VS 2026 Figure 2. Monoclonal Antibodies Features Figure 3. Personalized Cancer Vaccines Features Figure 4. Other Features Figure 5. Global Personalized Cancer Medicine Market Share by Application: 2020 VS 2026 Figure 6. Breast Cancer Case Studies Figure 7. Lung Cancer Case Studies Figure 8. Chronic Myeloid Leukaemia Case Studies Figure 9. Bowel Cancer Case Studies Figure 10. Other Cancer Case Studies Figure 11. Personalized Cancer Medicine Report Years Considered Figure 12. Global Personalized Cancer Medicine Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Personalized Cancer Medicine Market Share by Regions: 2020 VS 2026 Figure 14. Global Personalized Cancer Medicine Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Personalized Cancer Medicine Market Share by Players in 2019 Figure 17. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Medicine as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2019 Figure 19. North America Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Personalized Cancer Medicine Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 28. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 32. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 34. Celgene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 36. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 38. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 40. Astellas Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 42. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 44. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 46. Agilent Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 48. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2015-2020) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Abbott Merck Novartis Amgen Celgene Bayer Roche Astellas Astrazeneca Johnson & Johnson Agilent Takeda